Abstract

Ergotamine Tartrate 2-mg Sublingual Tablets

Author(s): Allen Loyd V Jr

Issue: May/Jun 2003 - Diabetes and Wound Care

Page(s): 219

Download in electronic PDF format for $75
  • Ergotamine Tartrate 2-mg Sublingual Tablets Page 1

Abstract

A formulation for preparing Ergotamine Tartrate 2-mg Sublingual Tablets. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • ergotamine
  • sublingual
  • tablet
  • headache
  • migraine
  • discontinued

Related Categories

  • FORMULATIONS
  • PAIN MANAGEMENT
  • DISCONTINUED FORMULATIONS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
May/Jun 2003
Pg. 219
Ergotamine Tartrate 2-mg Sublingual Tablets
Author(s): Allen Loyd V Jr
Nov/Dec 2012
Pg. 506
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules
Author(s): Allen Loyd V Jr
Jul/Aug 2012
Pg. 270-274
A Concise Discussion of Headache Types, Part 3: Migraine
Author(s): Williams LaVonn A, Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2003
Pg. 138
Lorazepam 2-mg Sublingual Tablets
Author(s): Allen Loyd V Jr
May/Jun 2023
Pg. 237
Migraine Headache Suppositories
Author(s): Allen Loyd V Jr
Mar/Apr 1998
Pg. 151
Ergotamine Tartrate, Caffeine, Hyoscyamine Sulfate and Pentobarbital Sodium Suppositories
Author(s): Allen Loyd V Jr
May/Jun 2002
Pg. 193
Medications Discontinued in the United States
Author(s): Ashworth Lisa D
May/Jun 2023
Pg. 240-249
An Alternative Approach to Tablet Splitting and Grinding for Medication Administration
Author(s): Taneja Rajneesh, Scarim Joseph, Pande Poonam G, Scarim Anthony, Nahata Milap C, Jew Rita K, Inabathina Koteswara Rao
Mar/Apr 2022
Pg. 163-174
Molding as Innovative Technology for Personalized Tablet Production
Author(s): Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
Mar/Apr 2020
Pg. 148-155
Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets
Author(s): Mahesparan Vishnu A/L, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai
Jul/Aug 2002
Pg. 300
Estriol 2-mg and Estradiol 0.5-mg/0.1-mL Sublingual Drops
Author(s): Allen Loyd V Jr
May/Jun 2012
Pg. 182-188
A Concise Discussion of Headache Types, Part 2: Migraine
Author(s): Williams LaVonn A
Jul/Aug 2002
Pg. 286-287
Medications Discontinued in the United States
Author(s): Ashworth Lisa D
May/Jun 2003
Pg. 233-239
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Author(s): Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2022
Pg. 255-263
Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets
Author(s): Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
Sep/Oct 2022
Pg. 370-377
Recent Formulation Advances and Preparation of Orally Disintegrating Tablets
Author(s): Ejeta Fikadu
Nov/Dec 2020
Pg. 509-514
Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract
Author(s): Azman Syahiera Ezzah Noor, Abd Razak Fashli Syafiq, Kamal Wan Hamirul Bahrin Wan, Zheng Gan Kok, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Sep/Oct 2024
Pg. 432-439
Enhancing Hormonal Tablets Disintegration: The Role of Chitosan as an Alternative Disintegrant in Estradiol Tablet Formulation
Author(s): Sembiring Mikael Ham, Riadi Taufik, Arsyadi
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr